These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 25253847)

  • 1. IKKβ deficiency in myeloid cells ameliorates Alzheimer's disease-related symptoms and pathology.
    Liu Y; Liu X; Hao W; Decker Y; Schomburg R; Fülöp L; Pasparakis M; Menger MD; Fassbender K
    J Neurosci; 2014 Sep; 34(39):12982-99. PubMed ID: 25253847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p38α-MAPK-deficient myeloid cells ameliorate symptoms and pathology of APP-transgenic Alzheimer's disease mice.
    Luo Q; Schnöder L; Hao W; Litzenburger K; Decker Y; Tomic I; Menger MD; Liu Y; Fassbender K
    Aging Cell; 2022 Aug; 21(8):e13679. PubMed ID: 35909315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of IKKβ in neurons ameliorates Alzheimer's disease pathology in APP- and tau-transgenic mice.
    Schnöder L; Quan W; Yu Y; Tomic I; Luo Q; Hao W; Peng G; Li D; Fassbender K; Liu Y
    FASEB J; 2023 Feb; 37(2):e22778. PubMed ID: 36688823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FBXW11 deletion alleviates Alzheimer's disease by reducing neuroinflammation and amyloid-β plaque formation via repression of ASK1 signaling.
    Sun J; Qin X; Zhang X; Wang Q; Zhang W; Wang M
    Biochem Biophys Res Commun; 2021 Apr; 548():104-111. PubMed ID: 33640602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice.
    Maier M; Peng Y; Jiang L; Seabrook TJ; Carroll MC; Lemere CA
    J Neurosci; 2008 Jun; 28(25):6333-41. PubMed ID: 18562603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commentary: research highlights: IKKβ mediates Aβ-triggered microglial inflammation and neuronal death during Alzheimer's disease.
    Fayaz SM; Rajanikant GK
    CNS Neurol Disord Drug Targets; 2014; 13(8):1305-7. PubMed ID: 25388359
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of P2Y₂ nucleotide receptors enhances early pathology in the TgCRND8 mouse model of Alzheimer's disease.
    Ajit D; Woods LT; Camden JM; Thebeau CN; El-Sayed FG; Greeson GW; Erb L; Petris MJ; Miller DC; Sun GY; Weisman GA
    Mol Neurobiol; 2014 Apr; 49(2):1031-42. PubMed ID: 24193664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IKK2/NF-κB Activation in Astrocytes Reduces amyloid β Deposition: A Process Associated with Specific Microglia Polarization.
    Yang S; Magnutzki A; Alami NO; Lattke M; Hein TM; Scheller JS; Kröger C; Oswald F; Yilmazer-Hanke D; Wirth T; Baumann B
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease.
    Magga J; Puli L; Pihlaja R; Kanninen K; Neulamaa S; Malm T; Härtig W; Grosche J; Goldsteins G; Tanila H; Koistinaho J; Koistinaho M
    J Neuroinflammation; 2010 Dec; 7():90. PubMed ID: 21138577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterozygous CX3CR1 Deficiency in Microglia Restores Neuronal β-Amyloid Clearance Pathways and Slows Progression of Alzheimer's Like-Disease in PS1-APP Mice.
    Hickman SE; Allison EK; Coleman U; Kingery-Gallagher ND; El Khoury J
    Front Immunol; 2019; 10():2780. PubMed ID: 31849963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment with Ginkgo biloba extract EGb 761 improves symptoms and pathology in a transgenic mouse model of Alzheimer's disease.
    Liu X; Hao W; Qin Y; Decker Y; Wang X; Burkart M; Schötz K; Menger MD; Fassbender K; Liu Y
    Brain Behav Immun; 2015 May; 46():121-31. PubMed ID: 25637484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MyD88 deficiency ameliorates β-amyloidosis in an animal model of Alzheimer's disease.
    Lim JE; Kou J; Song M; Pattanayak A; Jin J; Lalonde R; Fukuchi K
    Am J Pathol; 2011 Sep; 179(3):1095-103. PubMed ID: 21763676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid Arginase 1 Insufficiency Exacerbates Amyloid-β Associated Neurodegenerative Pathways and Glial Signatures in a Mouse Model of Alzheimer's Disease: A Targeted Transcriptome Analysis.
    Ma C; Hunt JB; Kovalenko A; Liang H; Selenica MB; Orr MB; Zhang B; Gensel JC; Feola DJ; Gordon MN; Morgan D; Bickford PC; Lee DC
    Front Immunol; 2021; 12():628156. PubMed ID: 34046031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct inflammatory phenotypes of microglia and monocyte-derived macrophages in Alzheimer's disease models: effects of aging and amyloid pathology.
    Martin E; Boucher C; Fontaine B; Delarasse C
    Aging Cell; 2017 Feb; 16(1):27-38. PubMed ID: 27723233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease pathology is attenuated in a CD38-deficient mouse model.
    Blacher E; Dadali T; Bespalko A; Haupenthal VJ; Grimm MO; Hartmann T; Lund FE; Stein R; Levy A
    Ann Neurol; 2015 Jul; 78(1):88-103. PubMed ID: 25893674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer's disease-related symptoms and pathology.
    Hao W; Liu Y; Liu S; Walter S; Grimm MO; Kiliaan AJ; Penke B; Hartmann T; Rübe CE; Menger MD; Fassbender K
    Brain; 2011 Jan; 134(Pt 1):278-92. PubMed ID: 21115468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice.
    Hickman SE; Allison EK; El Khoury J
    J Neurosci; 2008 Aug; 28(33):8354-60. PubMed ID: 18701698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenascin-C deficiency ameliorates Alzheimer's disease-related pathology in mice.
    Xie K; Liu Y; Hao W; Walter S; Penke B; Hartmann T; Schachner M; Fassbender K
    Neurobiol Aging; 2013 Oct; 34(10):2389-98. PubMed ID: 23673309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.